MASLD shares a common pathogenesis with cardiometabolic diseases, especially type 2 diabetes, primarily driven by unhealthy dietary habits, dysfunctional adipose tissue, insulin resistance and low-grade inflammation
Most prescribers suggest avoiding alcohol on injection day and the day after, because plasma drug concentrations rise during that window and gastrointestinal sensitivity tends to be highest then
Iso H, Moriyama Y, Sato S, et al
Gamma-glutamylcysteine is applicable to research related to inflammatory bowel disease, type 2 diabetes, cadmium-induced neurotoxicity, Alzheimer's disease, cerebral ischemia/reperfusion injury, neuropathy, and alcoholic liver disease
Tirzepatide also showed improvements in lipids and cardiovascular risk factors compared to dulaglutide 1.5 mg and placebo
The concentration is printed on the vial label